Summary

MTNR1B rs10830963 is one of the strongest gene-behaviour interactions in chrono-nutrition — the G risk allele increases melatonin receptor expression in pancreatic beta cells, causing melatonin to more potently suppress insulin secretion, which means late eating is metabolically worse for carriers and early dinner timing becomes a genuinely actionable intervention.

Genotype spectrum

CC

You have metabolic flexibility around meal timing. Late eating is less metabolically problematic for you than for G carriers.

CG

You have a clear, actionable lever: meal timing. The research shows that the metabolic penalty from this allele is largely eliminated by eating dinner earlier.

GG

Meal timing is your single most impactful dietary intervention. For GG carriers, early eating isn't a nice-to-have — it's a core metabolic strategy.

Practical takeaway

For CC Carriers (Reference)
• No MTNR1B-specific intervention needed.
• General circadian eating advice: earlier dinner is better for everyone, but you don't carry the specific genetic penalty.
• Focus on overall diet quality and macronutrient composition.
For CG Carriers (One Copy)

Meal timing:
• Finish eating 3+ hours before bedtime.
• Make dinner your smallest or most moderate meal — lunch can be your largest.
• Choose low-glycemic foods for evening meals: protein, healthy fats, non-starchy vegetables, legumes.
• Brief post-dinner walk (10-15 min) helps improve glucose clearance.

Monitoring:
• Check fasting glucose annually as part of routine bloodwork.
• If fasting glucose trends upward (>5.6 mmol/L), meal timing becomes a higher priority.
For GG Carriers (Homozygous — Highest Risk)

Strict meal timing protocol:
• Finish eating 4+ hours before sleep. If you sleep at 11pm, last food by 7pm.
• Eating window: 10-12 hours maximum (e.g., 7am-6pm). Shorter is fine if sustainable.
• Breakfast and lunch can include carbohydrates. Evening meal: emphasise protein + fat + fibre, minimise fast carbs.
• Post-dinner walk: 10-15 min. Non-negotiable habit.
• No caloric drinks after dinner (herbal tea is fine).

Glucose monitoring:
• Consider a 2-week CGM trial (Libre, Dexcom). Eat the same meal at 12pm and 8pm on different days and observe the difference. This is eye-opening data for GG carriers and builds intrinsic motivation for early eating.
• Annual fasting glucose and HbA1c. Target: fasting glucose <5.6 mmol/L, HbA1c <5.7%.

If shift work or social eating makes early dinner difficult:
• When late eating is unavoidable, choose the lowest glycemic option available.
• Vinegar (1-2 tbsp diluted in water before a meal) has modest evidence for blunting glucose spikes.
• Don't eat in the 2 hours immediately before sleep regardless.
• Meal prep to avoid the "too tired to cook, so I'll eat late" pattern.

Expected response window: Meal timing changes produce measurable fasting glucose improvements within 2-4 weeks. CGM data shows immediate effects on post-meal glucose responses.

Evidence detail

What This Gene Does

MTNR1B encodes the melatonin receptor MT2 (Mel1B), a G-protein-coupled receptor that binds melatonin — the hormone produced by the pineal gland in response to darkness. MT2 is expressed in multiple tissues, but the critical location for this variant's health impact is the pancreatic beta cell. When melatonin binds MT2 on beta cells, it activates Gi proteins, which inhibit adenylyl cyclase, reduce intracellular cAMP, and suppress insulin secretion. This is a normal physiological mechanism: at night, when melatonin is high, insulin secretion is suppressed because you shouldn't be eating.

The rs10830963 variant (C>G) sits in an intron of MTNR1B but has been functionally mapped to a cis-regulatory element that increases MTNR1B expression in beta cells. The G risk allele leads to higher MT2 receptor density on beta cells, which means melatonin more potently suppresses insulin secretion in carriers. During daylight hours, when melatonin is low, this doesn't matter much. But during the evening melatonin rise (which begins 2-3 hours before habitual bedtime), G allele carriers have impaired glucose tolerance because their beta cells are more sensitive to melatonin's insulin-suppressing effect.

This is one of the strongest GWAS hits for type 2 diabetes risk (Prokopenko et al. 2009), and crucially, the risk is modifiable by behaviour. The MTNR1B effect is almost entirely mediated through late eating — carriers who eat dinner early (3+ hours before sleep) largely eliminate the excess diabetes risk. This makes it one of the most directly actionable genetic findings in metabolic health.

Mechanism

The melatonin-insulin axis:

Melatonin is produced by the pineal gland in response to darkness, with levels rising 2-3 hours before habitual sleep onset (dim-light melatonin onset, or DLMO). Melatonin serves as a circadian signal to peripheral tissues, including the pancreas.

Pancreatic beta cells express MT2 receptors (encoded by MTNR1B). When melatonin binds MT2:
1. Gi protein activates → inhibits adenylyl cyclase → reduces intracellular cAMP.
2. Lower cAMP → reduced protein kinase A (PKA) activity → reduced exocytosis of insulin-containing granules.
3. Net effect: Insulin secretion is suppressed.

This is physiologically appropriate at night — you shouldn't be eating, so you don't need insulin. The problem arises when you eat during the melatonin window.

What the G allele changes:

The G allele at rs10830963 increases MTNR1B transcription through a cis-regulatory mechanism (Tuomi 2016). More MTNR1B mRNA → more MT2 protein → more receptors on the beta cell surface → enhanced sensitivity to melatonin's insulin-suppressing effect.

When a G carrier eats dinner at 9pm (after melatonin has begun to rise):
1. Food enters the GI tract → glucose rises in blood.
2. Beta cells should secrete insulin to handle the glucose.
3. But melatonin is already binding MT2 receptors, suppressing insulin secretion.
4. In G carriers, this suppression is stronger (more receptors).
5. Result: glucose stays elevated longer, peaks higher, and the overall glycemic exposure is greater.

Over years, this repeated elevated glucose exposure contributes to beta cell stress, insulin resistance development, and ultimately type 2 diabetes. The per-allele OR of 1.09 may seem small, but it compounds over decades and interacts with other metabolic risk factors.

The intervention logic:

If the metabolic harm comes from eating during the melatonin window, the fix is simple: don't eat during the melatonin window. Finishing dinner 3-4 hours before sleep means glucose processing is largely complete before melatonin rises. The beta cell doesn't need to secrete much insulin at the time when melatonin would suppress it.

This is one of the cleanest gene-behaviour interactions in metabolic genetics — the mechanism is clear, the intervention is obvious, and the evidence supports it.

MTNR1B Melatonin

Summary

Genotype spectrum

Practical takeaway

Evidence detail

Sources (11)